Drug Detail

Information about Mixed Bacterial Vaccine (MBV)

Generic Name
 Mixed Bacterial Vaccine (MBV)
IND
Brand Name (US)
Manufacturer
 Cobra Biomanufacturing Plc
Drug Type
 Virotherapy
Delivery
 Subcutaneous
Approval Status
 Unknown
Indications
Overall Strategy
 GIST cell based
Strategy
 Stimulate the immune system
Drug Category
 Virotherapy

Links

Trials of this drug

  

 A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen.
   

Trial results
  Phase I Clinical Trial of Mixed Bacterial Vaccine (Coley's Toxins) in Patients with NY-ESO-1 Expressing Cancers: Immunological Effects and Clinical Activity
   

Search for this drug/combination in:

ClinicalTrials.gov

ASCO

Pubmed